Equipe 2 cancer - STROMALab - Médecine régénératrice, thérapie cellulaire, cellules souches mésenchymateuses, tissu adipeux, moelle osseuse, réparation, régénération Regenerative medicine, cell therapy, mesenchymal stem cells, adipose tissue, bone marrow, repair, regeneration

Publications » FTY720 (Fingolimod) Inhibits HIF1 and HIF2 Signaling, Promotes Vascular Remodeling, and Chemosensitizes in Renal Cell Carcinoma Animal Model.

2016 | Angiogénèse, cancer, HIF, hypoxie

Gstalder C, Ader I*, Cuvillier O*. Mol Cancer Ther. *Co-corresponding authors

Publications » Essential role for SphK1/S1P signaling to regulate hypoxia-inducible factor 2α expression and activity in cancer.

2016 | Angiogénèse, cancer, HIF, hypoxie

Bouquerel P, Gstalder C, Müller D, Laurent J, Brizuela L, Sabbadini RA, Malavaud B, Pyronnet S, Martineau Y, Ader I*, Cuvillier O*. Oncogenesis. *Co-corresponding authors

Publications » Neutralizing S1P inhibits intratumoral hypoxia, induces vascular remodelling and sensitizes to chemotherapy in prostate cancer.

2015 | Angiogénèse, cancer, HIF, hypoxie

Ader I, Gstalder C, Bouquerel P, Golzio M, Andrieu G, Zalvidea S, Richard S, Sabbadini RA, Malavaud B, Cuvillier O. Oncotarget.

Mot-clé : "cancer" » 3 résultats

Publications » FTY720 (Fingolimod) Inhibits HIF1 and HIF2 Signaling, Promotes Vascular Remodeling, and Chemosensitizes in Renal Cell Carcinoma Animal Model.

Publications » Essential role for SphK1/S1P signaling to regulate hypoxia-inducible factor 2α expression and activity in cancer.

Publications » Neutralizing S1P inhibits intratumoral hypoxia, induces vascular remodelling and sensitizes to chemotherapy in prostate cancer.

STROMALab

Actualités

Premier prix AFH 2018 pour Nicolas GAIDE

ESOF 2018 : Stand StromaLab au village des sciences

Mot-clé : "cancer" » 3 résultats

Publications » FTY720 (Fingolimod) Inhibits HIF1 and HIF2 Signaling, Promotes Vascular Remodeling, and Chemosensitizes in Renal Cell Carcinoma Animal Model.

Publications » Essential role for SphK1/S1P signaling to regulate hypoxia-inducible factor 2α expression and activity in cancer.

Publications » Neutralizing S1P inhibits intratumoral hypoxia, induces vascular remodelling and sensitizes to chemotherapy in prostate cancer.

STROMALab

Actualités

Premier prix AFH 2018 pour Nicolas GAIDE

ESOF 2018 : Stand StromaLab au village des sciences

Recherche par mots-clés